Yahoo Web Search

Search results

1. www.marketbeat.com › stocks › NASDAQHeron Therapeutics (HRTX) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · Should You Buy or Sell Heron Therapeutics Stock? Get The Latest HRTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

   • Earnings

     Its stock price plummeted by over 14% in after-hours trading...

   • Chart

     View Heron Therapeutics (NASDAQ:HRTX) historical prices,...

   • Competitors

     Heron Therapeutics has a beta of 1.8, suggesting that its...

   • Insider Trades

     According to the Securities & Exchange Commission (SEC)...

   • Institutional Ownership

     During the previous two years, 112 institutional investors...

   • Short Interest

     A short interest ratio ranging between 1 and 4 generally...

2. www.marketbeat.com › stocks › NASDAQHeron Therapeutics (HRTX) Stock Forecast & Price Target

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Heron Therapeutics is $6.00, with a high forecast of $7.00 and a low forecast of $5.00.

   • 4.1/5
   • Phone: (858) 251-4400

   • Location: 4242 CAMPUS POINT COURT SUITE 200, SAN DIEGO CA, 92121
   • Email: ir@herontx.com

3. stockanalysis.com › stocks › hrtxHeron Therapeutics, Inc. (HRTX) - Stock Analysis

   stockanalysis.com › stocks › hrtx

   • Cached

   Oct 25, 2024 · Analyst Forecast. According to 3 analysts, the average rating for HRTX stock is "Strong Buy." The 12-month stock price forecast is $6.0, which is an increase of 237.08% from the latest price.

   • Market Cap: 274.52M
   • Revenue (ttm): 136.36M

   • Net Income (ttm): 48.13M
   • Shares Out: 151.67M

   • 
   • 
   • 
   • 

4. stockanalysis.com › stocks › hrtxHeron Therapeutics Stock Forecast - Stock Analysis

   stockanalysis.com › stocks › hrtx

   • Cached

   3 days ago · Stock Price Forecast. The 3 analysts with 12-month price forecasts for Heron Therapeutics stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 246.82% from the current stock price of 1.73.

5. www.zacks.com › HRTX › price-target-stock-forecastWhat is the current Price Target and Forecast for Heron ...

   www.zacks.com › HRTX › price-target-stock-forecast

   • Cached

   4 days ago · Based on short-term price targets offered by five analysts, the average price target for Heron Therapeutics comes to $6.80. The forecasts range from a low of $5.00 to a high of $9.00.

6. seekingalpha.com › article › 4655013-why-heronWhy Heron Therapeutics Is A Compelling Buy Into 2024

   seekingalpha.com › article › 4655013-why-heron

   Nov 30, 2023 · Heron Therapeutics underwent a leadership change and implemented a plan to improve efficiency and profitability. Find out why HRTX stock is a good buy.

7. People also ask

   What is hrtx Heron Therapeutics (hrtx) stock price?

   • Search for Symbols, analysts, keywords Log in HRTX Heron Therapeutics, Inc. Stock Price & Overview Follow $1.74-0.10(-5.71%)1:53 PM 10/14/24

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/HRTX

   See all results for this question

   What is the 12-month price forecast for heron Therapeutics (hrtx)?

   • The 12-month stock price forecast is $6.0, which is an increase of 226.09% from the latest price. SAN DIEGO , Oct. 10, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today reaffirmed the Company's ability to supply...

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Is Heron Therapeutics a good stock to buy?

   • Heron Therapeutics scored higher than 77% of companies evaluated by MarketBeat, and ranked 272nd out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Earnings and Valuation 0.0 / 5Proj.

   Heron Therapeutics (HRTX) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/HRTX/

   See all results for this question

   Should you buy Heron Therapeutics (hrtx) in 2023?

   • In 2023, Heron Therapeutics's revenue was $127.04 million, an increase of 17.99% compared to the previous year's $107.67 million. Losses were -$110.56 million, -39.26% less than in 2022. According to 3 analysts, the average rating for HRTX stock is "Strong Buy."

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Is Heron Therapeutics a good stock to sell before Election Day?

   • For all the details, including the #1 stock to SELL before Election Day, click here. Heron Therapeutics scored higher than 77% of companies evaluated by MarketBeat, and ranked 272nd out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

   Heron Therapeutics (HRTX) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/HRTX/

   See all results for this question

   Who is Heron Therapeutics?

   • Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care.

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

8. seekingalpha.com › symbol › HRTXHeron Therapeutics, Inc. (HRTX) Stock Price, Quote, News ...

   seekingalpha.com › symbol › HRTX

   4 days ago · What are your Heron Therapeutics, Inc. (HRTX) stock predictions? 4 Wall Street analysts have issued ratings. Currently, 4 analysts rated HRTX as Bullish, 0 rated it Bearish, and 0 rated it...